BALAXI.NS Живые сигналы | Максимизируйте прибыль с Getagraph.com

Live Chart Being Loaded With Signals

Commentary (6 май 2024 @ 12:59):

Balaxi Ventures Ltd. engages in the wholesale trading of pharmaceuticals, food products, and hardware. The company is headquartered in Hyderabad, Telangana...

Stats
Объем за сегодня	3 907.00
Средний объем	21 936.00
Рыночная капитализация	6.61B
EPS	INR14.06 ( 2023-09-30 )
Last Dividend	INR0.500 ( 2022-07-01 )
Next Dividend	INR0 ( N/A )
P/E	-117.76
ATR14	INR0.801 (0.13%)

Объем Корреляция

Длинно: 0.06 (neutral)

Кратко: 0.63 (weak)

Signal:(52.372) Neutral

Balaxi Pharmaceuticals Корреляция

10 Самые положительные корреляции
LAKSHVILAS.NS	0.837
ASIANPAINT.NS	0.829
KIRIINDUS.NS	0.822
BGLOBAL.NS	0.819
DIXON.NS	0.802
DMART.NS	0.801

10 Самые отрицательные корреляции
DFMFOODS.NS	-0.833
TOUCHWOOD.NS	-0.827

Вы знали?

Корреляция - это статистический показатель, описывающий связь между двумя переменными. Он изменяется от -1 до 1, где -1 указывает на идеальную отрицательную корреляцию (при увеличении одной переменной другая уменьшается), 1 указывает на идеальную положительную корреляцию (при увеличении одной переменной другая увеличивается), а 0 указывает на отсутствие корреляции (между переменными нет связи).

Корреляцию можно использовать для анализа связи между любыми двумя переменными, не только акциями. Она широко используется в таких областях, как финансы, экономика, психология и т. д.

Balaxi Pharmaceuticals Корреляция - Валюта/Сырье

-0.09
( neutral )

-0.42
( neutral )

-0.32
( neutral )

-0.03
( neutral )

-0.26
( neutral )

-0.23
( neutral )

Balaxi Pharmaceuticals Финансовые показатели

Annual	2022
Выручка:	INR3.36B
Валовая прибыль:	INR1.34B (39.83 %)
EPS:	INR45.81

FY	2022
Выручка:	INR3.36B
Валовая прибыль:	INR1.34B (39.83 %)
EPS:	INR45.81

FY	2022
Выручка:	INR2.79B
Валовая прибыль:	INR837.92M (29.99 %)
EPS:	INR47.66

FY	2021
Выручка:	INR2.31B
Валовая прибыль:	INR591.85M (25.58 %)
EPS:	INR38.14

Financial Reports:

No articles found.

Balaxi Pharmaceuticals Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR0.500 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Balaxi Pharmaceuticals Dividend Information - No Dividend Player

Dividend Sustainability Score: 2.50 - low (50.00%) | Divividend Growth Potential Score: 0.0536 - No dividend growth expected in the near future

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	INR0.500	2022-07-01
Last Dividend	INR0.500	2022-07-01
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	1	--
Total Paid Out	INR0.500	--
Avg. Dividend % Per Year	0.02%	--
Score	0.4	--
Div. Sustainability Score	2.50
Div.Growth Potential Score	0.0536
Div. Directional Score	1.279	--

Next Divdend (Est)
(2024-05-06)

INR0 Estimate 0.00 %

Dividend Stability

0.04 Very Bad

Dividend Score

0.40

Pay Frequency

Insufficient data to determine frequency

Yearly Payout

Year	Amount	Yield
2022	INR0.500	0.10%
2023	INR0	0.00%
2024	INR0	0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
SANDHAR.NS	Dividend Junior	2023-09-14	Annually	7	0.66%
LXCHEM.NS	Dividend Junior	2023-07-20	Annually	4	0.11%
GLENMARK.NS	Dividend Junior	2023-09-18	Annually	23	0.37%
ASIANPAINT.NS	Dividend Junior	2023-06-09	Semi-Annually	23	0.43%
TINPLATE.NS	Dividend Junior	2023-08-11	Annually	19	0.72%
PDMJEPAPER.NS	Dividend Junior	2023-08-03	Annually	9	0.65%
J&KBANK.NS	Dividend Junior	2023-08-17	Sporadic	22	0.47%
DATAMATICS.NS	Dividend Junior	2023-09-22	Annually	21	0.49%
SHYAMMETL.NS	Dividend Junior	2023-06-05	Semi-Annually	4	0.70%
MAXHEALTH.NS	Dividend Junior	2023-09-08	Insufficient data to determine frequency	2	0.07%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-0.0199	1.500	-0.398	-0.597	[0 - 0.5]
returnOnAssetsTTM	0	1.200	0	0	[0 - 0.3]
returnOnEquityTTM	-0.0309	1.500	-1.454	-2.18	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0	0.800	-5.00	-4.00	[1 - 3]
quickRatioTTM	0	0.800	-4.71	-3.76	[0.8 - 2.5]
cashRatioTTM	0	1.500	-1.111	-1.667	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	31.60	1.000	10.00	10.00	[3 - 30]
operatingCashFlowPerShareTTM	3.82	2.00	8.73	10.00	[0 - 30]
freeCashFlowPerShareTTM	3.82	2.00	8.09	10.00	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.424	1.000	6.26	6.26	[0.2 - 0.8]
operatingProfitMarginTTM	0.161	1.000	8.77	8.77	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				2.50

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-119.98	1.000	-10.00	0	[1 - 100]
returnOnEquityTTM	-0.0309	2.50	-0.935	-2.18	[0.1 - 1.5]
freeCashFlowPerShareTTM	3.82	2.00	8.73	10.00	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	3.82	2.00	8.73	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0	1.500	-3.33	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0149	1.000	-2.13	0	[0.1 - 0.5]
Total Score				0.0536

Balaxi Pharmaceuticals

Balaxi Ventures Ltd. engages in the wholesale trading of pharmaceuticals, food products, and hardware. The company is headquartered in Hyderabad, Telangana. The Company’s products include pharmaceuticals products, food products and builders’ hardware products. The company operates through the operating segment international wholesale trading. Its pharmaceutical formulations and builders’ hardware products are contract manufactured from manufacturing plants in India. The firm offers a range of food and biscuit products under the brand name YAP. Its subsidiaries include Balaxi Global DMCC.